Drug Shortage Report for TYPHIM VI

Last updated on 2020-06-25 History
Report ID 108651
Drug Identification Number 02130955
Brand name TYPHIM VI
Common or Proper name Salmonella typhi Vi Capsular Polysaccharide Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 25MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1 x 0.5 mL (single dose) syringe
ATC code J07AP
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-03-11
Actual start date 2020-03-11
Estimated end date 2020-07-31
Actual end date 2020-06-24
Shortage status Resolved
Updated date 2020-06-25
Company comments (Shortage resolved as of June 24, 2020) PFS presentation inventory is on allocation for public market. MDV presentation is available to order in private market.
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-06-25 English Compare
v5 2020-06-24 French Compare
v4 2020-06-24 English Compare
v3 2020-03-13 French Compare
v2 2020-03-13 French Compare
v1 2020-03-13 English Compare

Showing 1 to 6 of 6